• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN ABRE VENOUS SELF-EXPANDING STENT SYSTEM; STENT, ILIAC VEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN ABRE VENOUS SELF-EXPANDING STENT SYSTEM; STENT, ILIAC VEIN Back to Search Results
Model Number AB9U14080090
Medical Device Problem Code Device Damaged by Another Device (2915)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/29/2022
Type of Reportable Event Malfunction
Event or Problem Description
Physician was attempting to use an abre self-expanding stent during the procedure along with non-medtronic 9fr sheath, 0.035" guidewire and an ivc filter in place for embolic protection during procedure.Thee was no damage noted to packaging.There was no issue noted when removing device from hoop/tray.Balloon inflation difficulties was reported with device slow to deflate at the lesion site, the balloon was a it was an atlas 14x40 from bard.Deflation issue noted during subsequent inflation and it was ballooned again.The lesion was pre dilated with a 14x40 device.The device passed through a previously deployed stent.There was no resistance encountered when advancing the device. it was reported that the new tech felt a lot of resistance when trying to deflate the balloon. balloon was removed and a piece of potential stent was attached to balloon.Got a new balloon and post dilated again.No vessel damage.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Image analysis four images were provided for evaluation.Three cine images and one still image was provided.In the three cine images you can see two stents.It was reported that the abre device did pass through a previously deployed stent hence why we can see two stents in the images.No damage can be observed to the stent in the still image.Image fourth is a still image.The still image is of a non medtronic balloon.The balloon is covered in biologics.You can see a string like material wrapped around the balloon and extending on to the surface.The balloon material appears to be pulled back proximally on its self and the string like material that can be observed, appears to be material from the balloon.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABRE VENOUS SELF-EXPANDING STENT SYSTEM
Common Device Name
STENT, ILIAC VEIN
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key15101226
Report Number2183870-2022-00239
Device Sequence Number4587990
Product Code QAN
UDI-Device Identifier00643169796294
UDI-Public00643169796294
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P200026
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/24/2025
Device Model NumberAB9U14080090
Device Catalogue NumberAB9U14080090
Device Lot NumberB359048
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/29/2022
Supplement Date Received by Manufacturer09/21/2022
Initial Report FDA Received Date07/26/2022
Supplement Report FDA Received Date09/22/2022
Date Device Manufactured03/25/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-